clinical trial · NCT06154304
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Bronchial AsthmaAlbuterol Sulfate Inhalation Aerosol (90 mcg per actuation)Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2Placebo
brief summary
The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product, using bronchoprovocation (methacholine challenge testing) in adult patients with stable mild asthma.
started
Dec 6, 2023
primary completion
Sep 16, 2024
completion
Nov 29, 2024
last updated
Jul 16, 2025
detailed description
This study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product in terms of FEV1 measured at different time-points, using bronchoprovocation (methacholine challenge testing) in adult patients with stable mild asthma.
official title
To Compare the Bronchoprotective Effects of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate Using Methacholine Bronchoprovocation Challenge Testing in Stable Mild Asthma Patients.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol